Publications
Detailed Information
Association of shared decision-making with type of breast cancer surgery: a cross-sectional study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Myung Kyung | - |
dc.contributor.author | Noh, Dong Young | - |
dc.contributor.author | Nam, Seok Jin | - |
dc.contributor.author | Ahn, Se Hyun | - |
dc.contributor.author | Lee, Eun Sook | - |
dc.contributor.author | Yun, Young Ho | - |
dc.contributor.author | Park, Byeong Woo | - |
dc.date.accessioned | 2012-06-28T08:56:52Z | - |
dc.date.available | 2012-06-28T08:56:52Z | - |
dc.date.issued | 2010-02-23 | - |
dc.identifier.citation | BMC HEALTH SERVICES RESEARCH; Vol.10; 48 | ko_KR |
dc.identifier.issn | 1472-6963 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77813 | - |
dc.description.abstract | Background: Although some studies examined the association between shared decision-making (SDM) and type of breast cancer surgery received, it is little known how treatment decisions might be shaped by the information provided by physicians. The purpose of this study was to identify the associations between shared decision making (SDM) and surgical treatment received. Methods: Questionnaires on SDM were administered to 1,893 women undergoing primary curative surgery for newly diagnosed stage 0-II localized breast cancer at five hospitals in Korea. Questions included being informed on treatment options and the patient`s own opinion in decision-making. Results: Patients more likely to undergo mastectomy were those whose opinions were respected in treatment decisions (adjusted odds ratio, aOR), 1.40; 95% confidence interval (CI), 1.14-1.72) and who were informed on chemotherapy (aOR, 2.57; CI, 2.20-3.01) or hormone therapy (aOR, 2.03; CI, 1.77-2.32). In contrast, patients less likely to undergo mastectomy were those who were more informed on breast surgery options (aOR, 0.34; CI, 0.27-0.42). In patients diagnosed with stage 0-IIa cancer, clinical factors and the provision of information on treatment by the doctor were associated with treatment decisions. In patients diagnosed with stage IIb cancer, the patient`s opinion was more respected in treatment decisions. Conclusion: Our population-based study suggested that women`s treatment decisions might be shaped by the information provided by physicians, and that women might request different information from their physicians based on their preferred treatment options. These results might need to be confirmed in other studies of treatment decisions. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BIOMED CENTRAL LTD | ko_KR |
dc.title | Association of shared decision-making with type of breast cancer surgery: a cross-sectional study | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이명경 | - |
dc.contributor.AlternativeAuthor | 노동영 | - |
dc.contributor.AlternativeAuthor | 남석진 | - |
dc.contributor.AlternativeAuthor | 안세현 | - |
dc.contributor.AlternativeAuthor | 박병우 | - |
dc.contributor.AlternativeAuthor | 이은숙 | - |
dc.contributor.AlternativeAuthor | 윤영호 | - |
dc.identifier.doi | 10.1186/1472-6963-10-48 | - |
dc.citation.journaltitle | BMC HEALTH SERVICES RESEARCH | - |
dc.description.citedreference | Collins ED, 2009, J CLIN ONCOL, V27, P519, DOI 10.1200/JCO.2008.16.6215 | - |
dc.description.citedreference | Bleicher RJ, 2008, ANN SURG ONCOL, V15, P854, DOI 10.1245/s10434-007-9708-x | - |
dc.description.citedreference | Fentiman IS, 2007, BREAST J, V13, P406 | - |
dc.description.citedreference | MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366 | - |
dc.description.citedreference | Katz SJ, 2005, J CLIN ONCOL, V23, P5526, DOI 10.1200/JCO.2005.06.217 | - |
dc.description.citedreference | Lantz PM, 2005, HEALTH SERV RES, V40, P745 | - |
dc.description.citedreference | Mazur DJ, 2005, HEALTH EXPECT, V8, P97 | - |
dc.description.citedreference | RAY JA, 2005, J GENET COUNS, V14, P473 | - |
dc.description.citedreference | Schofield PE, 2004, PATIENT EDUC COUNS, V55, P32, DOI 10.1016/j.pec.2003.07.001 | - |
dc.description.citedreference | Maly RC, 2004, J AM GERIATR SOC, V52, P1138 | - |
dc.description.citedreference | Baxter NN, 2004, J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069 | - |
dc.description.citedreference | Demicheli R, 2004, J CLIN ONCOL, V22, P102, DOI 10.1200/JCO.2004.12.139 | - |
dc.description.citedreference | Whitney SN, 2003, MED DECIS MAKING, V23, P275, DOI 10.1177/0272989X03256006 | - |
dc.description.citedreference | FORD S, 2003, HLTH EXPECTATIONS, V6, P72 | - |
dc.description.citedreference | Keating NL, 2002, J CLIN ONCOL, V20, P1473 | - |
dc.description.citedreference | Liang WH, 2002, J CLIN ONCOL, V20, P1008 | - |
dc.description.citedreference | Katz SJ, 2001, J WOMEN HEALTH GEN-B, V10, P659 | - |
dc.description.citedreference | Bruera E, 2001, J CLIN ONCOL, V19, P2883 | - |
dc.description.citedreference | Elwyn G, 2001, PATIENT EDUC COUNS, V43, P5 | - |
dc.description.citedreference | Mandelblatt JS, 2001, MED CARE, V39, P228 | - |
dc.description.citedreference | Cyran EM, 2001, ARCH SURG-CHICAGO, V136, P185 | - |
dc.description.citedreference | Robins JM, 2000, EPIDEMIOLOGY, V11, P550 | - |
dc.description.citedreference | SIMINOFF LA, 2000, HLTH EXPECTATIONS, V3, P26 | - |
dc.description.citedreference | Fallowfield L, 1999, EUR J CANCER, V35, P1592 | - |
dc.description.citedreference | Whelan T, 1999, J CLIN ONCOL, V17, P1727 | - |
dc.description.citedreference | OCONNOR AM, 1999, J NATL CANC I MONOGR, V25, P67 | - |
dc.description.citedreference | VERHOEF MJ, 1999, CANC PREV CONTROL, V3, P181 | - |
dc.description.citedreference | Guadagnoli E, 1998, J CLIN ONCOL, V16, P101 | - |
dc.description.citedreference | Ganz PA, 1997, CANCER, V80, P1323 | - |
dc.description.citedreference | Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485 | - |
dc.description.citedreference | Albain KS, 1996, J CLIN ONCOL, V14, P3009 | - |
dc.description.citedreference | Cameron C, 1996, J ADV NURS, V24, P244 | - |
dc.description.citedreference | Deber RB, 1996, ARCH INTERN MED, V156, P1414 | - |
dc.description.citedreference | BallardBarbash R, 1996, J NATL CANCER I, V88, P716 | - |
dc.description.citedreference | MARGOLESE RG, 1994, CAN MED ASSOC J, V150, P331 | - |
dc.description.citedreference | NATTINGER AB, 1992, NEW ENGL J MED, V326, P1102 | - |
dc.description.citedreference | SLEVIN ML, 1990, BRIT MED J, V300, P1458 | - |
dc.description.citedreference | POTTER F, 1990, P SURV RES METH SECT, P225 | - |
dc.description.citedreference | SIMINOFF LA, 1989, J CLIN ONCOL, V7, P1192 | - |
dc.description.citedreference | LEVY SM, 1989, J CLIN ONCOL, V7, P367 | - |
dc.description.citedreference | ENDE J, 1989, J GEN INTERN MED, V4, P23 | - |
dc.description.citedreference | MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355 | - |
dc.description.citedreference | TAN Z, 48 J HOPK U DEP BIOS | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.